Tipsheet
What matters at India’s listed companies
Earnings · Trading · Micro cap

Chembond Chemicals Q1 profit surges 52% to ₹9.5 cr

Consolidated revenue rises 32% to ₹86.5 crore, driven by water treatment and industrial hygiene volumes. Standalone PAT more than doubles to ₹2.7 crore despite flat turnover.


Mkt cap₹607 cr
P/E17.36×
ROE17.75%
Debt / eq.0.00
Div yld0.58%
₹9.5 cr Net profit attributable to shareholders, up 52% YoY

What's new

  • Consolidated revenue jumped 32% YoY to ₹86.5 crore.
  • Net profit attributable to shareholders rose 52% to ₹9.5 crore.
  • Standalone PAT more than doubled to ₹2.7 crore despite flat revenue.

Why this matters

Chembond's strong Q1 performance confirms the growth trajectory in specialty chemicals, with effective cost management boosting margins. For a micro-cap with zero debt and a trailing P/E of 17.4, the earnings beat strengthens its valuation case.

What we're watching

  • Sustainability of volume growth in water treatment and industrial hygiene segments.
  • Whether standalone revenue can turn positive in coming quarters.
  • Any updates on new product launches or capacity expansion.

The full read

Chembond Chemicals kicked off FY27 with a sharp Q1 beat. Consolidated revenue rose 32% to ₹86.5 crore, while net profit attributable to shareholders surged 52% to ₹9.5 crore (driven by strong volume growth in water treatment and industrial hygiene). On a standalone basis, turnover was flat at ₹18.4 crore, but profit after tax more than doubled to ₹2.7 crore, aided by lower input costs. The results exceed the company's trailing growth rates of 29.9% (revenue) and 33.9% (PAT). For a zero-debt micro-cap with a P/E of 17.4, the earnings momentum reinforces the valuation story. Yet the filing is routine, with no new strategic updates or guidance. The real test now is whether volume growth can sustain through the rest of the year. So far, the trajectory looks strong.

Questions answered

What drove the 32% consolidated revenue growth?
Strong volume growth in the water treatment and industrial hygiene businesses, part of Chembond's specialty chemicals portfolio.
Why did standalone revenue stay flat while consolidated grew sharply?
Standalone turnover was flat at ₹18.4 crore, but profit after tax more than doubled to ₹2.7 crore due to lower input cost pressures. The growth came from other segments consolidated.
What is Chembond's debt position?
Chembond has zero debt, with a debt-to-equity ratio of 0.00 as per the latest available data.
How does this quarter's performance compare to its trailing growth?
Trailing revenue growth was 29.9% and PAT growth 33.9%. This quarter surpassed both with 32% revenue and 52% PAT growth.
Is this a routine filing?
Yes, it is a standard quarterly results disclosure approved by the board, accompanied by a limited review report. No new strategic updates or forward guidance were provided.
What are Chembond's key valuation metrics?
Market cap is ₹607 crore, trailing P/E of 17.4, and ROE of 17.8%.
Mentioned: ₹86.5 cr revenue · ₹9.5 cr net profit · 52% profit growth
Primary source BSE · NSE · Tijori

An independent reading of the company's own disclosure — the primary filing above is the final word.

Company snapshot

Chembond Chemicals Ltd.

Miscellaneous
₹662 cr
P/E 17.30×

Latest quarter · Jun 2026

Sales₹86 cr
Net profit₹10 cr
Op. margin+13.1%
EPS₹3.54

Strength & growth

Debt / equity0.00×
Current ratio5.10×